Cowen Healthcare Investments (investor - Private Equity)

United States
See something wrong or missing? Let us know
Offices:New York

Cowen Healthcare Investments (CHI) makes mid-to-late stage investments into innovative private biopharmaceutical and healthcare companies on behalf of Cowen Inc, a diversified financial services firm offering investment banking services, equity and credit research.

Average round investment:94.69M USD
Average number per year:1.0
Distribution: 2022 (1)2021 (1)
Portfolio companies: United Kingdom F2GSwitzerland Anaveon
Mostly invests in: United Kingdom United Kingdom (1) Biotech (2)

2 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Cowen Healthcare Investments

Name Criteria
Switzerland Julius Bär Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Artis Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Gilde Healthcare
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Tekla Capital Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Belgium Novalis Biotech
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Emerson Collective
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Arch Venture Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Honeywell Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Prime Movers Labs
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top